1. Home/
  2. Compounds/
  3. decitabine:navitoclax (2:1 mol/mol)

decitabine:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2decitabine:navitoclax (2:1 mol/mol)
PharmacoGx decitabine:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to decitabine:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA TTC3 CTRPv2 pan-cancer AAC 0.18 2e-08
mRNA ZNF461 CTRPv2 pan-cancer AAC 0.18 2e-08
mRNA NPIPA1 CTRPv2 pan-cancer AAC 0.18 2e-08
mRNA CBX2 CTRPv2 pan-cancer AAC 0.2 2e-08
mRNA USP11 CTRPv2 pan-cancer AAC 0.18 2e-08
mRNA MADD CTRPv2 pan-cancer AAC 0.18 2e-08
mRNA NTN3 CTRPv2 pan-cancer AAC 0.18 2e-08
mRNA ZNF136 CTRPv2 pan-cancer AAC 0.19 2e-08
mRNA PELI2 CTRPv2 pan-cancer AAC 0.17 2e-08
mRNA SYP CTRPv2 pan-cancer AAC 0.18 2e-08
Download CSV